Codone Biotech

Codone Biotech is a biopharmaceutical company headquartered in Hangzhou, China, dedicated to the development of innovative circular RNA (circRNA) therapeutics. The company utilizes a proprietary platform to engineer circRNA molecules that offer superior stability and prolonged protein expression compared to conventional linear mRNA. Codone Biotech's pipeline includes candidates for infectious disease vaccines, cancer immunotherapy, and rare disease treatments, all supported by advanced lipid nanoparticle delivery technologies. By focusing on the unique structural advantages of circular RNA, the company aims to create a new generation of highly effective and durable RNA-based medicines. The firm has successfully raised significant venture capital to advance its platform and move its lead candidates toward clinical trials.